Amino acid changes in advanced ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how ovarian cancer changes the body's use of amino acids, which are building blocks of proteins. It may help find new ways to monitor or treat the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of ovarian cancer called high-grade serous that is advanced (stage III or IV) and cannot be removed with surgery right away.
- You must be treated or followed at Grenoble Alpes University Hospital in France.
- You must be enrolled in French social security.
- You cannot be on a vegetarian or vegan diet.
- You cannot have certain metabolic disorders (like problems breaking down amino acids), diabetes, or organ failure needing long-term treatment.
- You cannot have liver metastases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic and other factors that may explain why some people with ovarian cancer respond well to platinum-based chemotherapy for many years, while others do not respond at all. The goal is to better understand these differences to improve future treatments.
This study looks at certain substances in the body (called metabolic biomarkers) and how they relate to how well patients do after treatment. It is for women who have just been diagnosed with high-grade serous ovarian cancer and have not yet had any treatment.
This study looks for specific gene mutations in the blood of ovarian cancer patients who have a BRCA mutation and are starting first-line maintenance therapy with a PARP inhibitor called Olaparib. It aims to better understand how these mutations may affect treatment response.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
This study tests whether adding a statin (a common cholesterol-lowering drug) to standard chemotherapy can improve outcomes for people with ovarian cancer. It's for women who are about to receive chemotherapy as part of their treatment plan.
This trial tests a different way of giving chemotherapy to people with advanced ovarian cancer that didn't respond well to initial treatment. The goal is to see if changing the dose and schedule can improve outcomes.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.